SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000897423-18-000054
Filing Date
2018-07-26
Accepted
2018-07-26 14:53:37
Documents
1
Period of Report
2018-07-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 3141
  Complete submission text file 0000897423-18-000054.txt   4785
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

IRS No.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRATTON CAPITAL MANAGEMENT 201 MAIN STREET, SUITE 1900 FORT WORTH TX 76102
Business Address C/O BRATTON CAPITAL MANAGEMENT 201 MAIN STREET, SUITE 1900 FORT WORTH TX 76102 817-339-7600
Monoline Partners, L.P. (Reporting) CIK: 0001747211 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38599 | Film No.: 18971411